Clinical Trial Update: Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating Aldesleukin in combination with Nivolumab and standard chemotherapy for clinical stage IV gastric cancer with perito…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastric Cancer
• Gastroesophageal Junction Cancer
• Peritoneal Metastasis

Drugs mentioned

• Aldesleukin (interleukin-2)
• Standard chemotherapy for gastric cancer (unspecified)
• nivolumab (nivolumab)

Snippet

Sponsor: Mayo Clinic | Conditions: Clinical Stage IV Gastric Cancer AJCC v8, Gastric Adenocarcinoma | Phase 1 | Status: RECRUITING